| Literature DB >> 33665446 |
Anisa Lutfia1, Erman Munir1, Yurnaliza Yurnaliza1, Mohammad Basyuni2.
Abstract
Zingiber griffithii Baker is one of the native Zingiberaceous species in a tropical forest of North Sumatra, Indonesia. Zingiberaceous species have been intensively studied and reported as herbal ingredients in ethnomedicine and currently their endophytic fungal associates were studied for pharmacological importance. Fifteen endophytic fungi were isolated from Zingiber griffithii following morphological and molecular characterization. All isolates exhibited antibacterial properties to at least one of the tested pathogenic bacteria Staphylococcus aureus, Escherichia coli, Methicilin-resistant S. aureus (MRSA), and Enteropathogenic E. coli (EPEC). The isolate, identified as Hypomontagnella monticulosa strain Zg15SU (syn. Hypoxylon monticulosum Mont.) based on its rDNA/ITS sequence, displayed antibacterial activities to all tested pathogens. The EtOAc extract of the H. monticulosum Zg15SU showed the highest activity for gram-negative bacteria, the E. coli and EPEC, while the extract of Z. griffithii rhizome displayed activity only for E. coli. The gas chromatography-mass spectrometry analysis (GC-MS) indicated a major portion of similar compounds found in both the endophytic fungus and plant extract, revealing the compounds of oleic acid, cyclononasiloxane, octadecamethyl, and eicosanoic acid Furthermore, purification and structural elucidation on the EtOAc extract of both Z. griffithii rhizome and H. monticulos a Zg15SU yielded two bioactive compounds: a novel compound, griffithiiene, a terpenoid-alkaloid bearing the skeleton of a scalarane (1) and scalaradial (2) which were confirmed by 1H- (500 MHz) and 13C-NMR (125 MHz) spectroscopy. Importantly, the elucidated compounds showed a cytotoxicity activity against cancer cell lines, the Panc-1, NBT-T2, and HCT116 based on in vitro MTT proliferation assay. This is the first report of Z. griffithii harboring an endophytic fungus, H. monticulosa, which produced potential antibacterial and anticancer metabolites along with its host to be utilized for future prospects.Entities:
Keywords: Anticancer; Hypomontagnella monticulosa; North sumatra; Sesterterpenoid; Zingiber griffithii Baker
Year: 2021 PMID: 33665446 PMCID: PMC7900702 DOI: 10.1016/j.heliyon.2021.e06292
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Wild Zingiber griffithii Baker in Tahura Tongkoh Bukit Barisan, Karo regency, North Sumatra, Indonesia. Scale bar: 10 cm.
Figure 2Dual culture antagonistic test on PDA+1% (w/v) yeast extract agar medium. Three agar plugs of isolate Zg15SU (A) was inoculated on top of a lawn of Methicilin-resistant Staphylococcus aureus ATCC® 43300™ (±1.2 × 108 CFU/mL). Following incubation at 25–28 °C, a clear zone around fungal plugs indicated a presence of inhibition (B) against bacterial law. This is compared to control agar plug without inoculation (C).
Antagonistic activity of endophytic fungi isolated from Zingiber griffithii rhizome.
| No | Isolate code | Inhibition zone (mm) | |||
|---|---|---|---|---|---|
| MRSA | EPEC | ||||
| 1 | Zg01SU | 20.00 ± 1.20 | n.d | n.d | n.d |
| 2 | Zg02SU | 22.27 ± 1.71 | 14.67 ± 1.04 | n.d | n.d |
| 3 | Zg03SU | 21.77 ± 2.87 | 13.33 ± 1.17 | 12.43 ± 0.49 | n.d |
| 4 | Zg04SU | 19.13 ± 0.55 | 15.07 ± 1.72 | n.d | n.d |
| 5 | Zg05SU | 19.90 ± 0.00 | 21.20 ± 4.08 | n.d | n.d |
| 6 | Zg06SU | 30.60 ± 2.45 | 18.47 ± 1.56 | n.d | n.d |
| 7 | Zg07SU | 24.73 ± 3.49 | 11.13 ± 1.86 | n.d | n.d |
| 8 | Zg08SU | 25.67 ± 2.06 | 17.53 ± 0.32 | n.d | n.d |
| 9 | Zg09SU | 21.07 ± 1.85 | 18.33 ± 2.90 | n.d | n.d |
| 10 | Zg10SU | 22.50 ± 1.64 | 22.07 ± 2.35 | n.d | 20.46 ± 0.95 |
| 11 | Zg11SU | 17.40 ± 2.86 | 16.77 ± 2.97 | n.d | n.d |
| 12 | Zg12SU | 23.73 ± 1.20 | 17.27 ± 3.98 | n.d | n.d |
| 13 | Zg13SU | 24.70 ± 1.30 | 17.70 ± 3.59 | n.d | n.d |
| 14 | Zg14SU | 26.50 ± 2.82 | 19.13 ± 3.30 | 9.70 ± 5.29 | n.d |
| 15 | |||||
| 16 | Zg16SU | 24.03 ± 2.39 | 24.53 ± 1.50 | n.d | n.d |
| 17 | Zg17SU | 23.10 ± 0.87 | 15.20 ± 5.00 | n.d | n.d |
n.d: no detectable inhibition zone.
This is to highlight the potential of our isolate for the next experimentation.
mean diameter of inhibition zone ±S.D. (n = 3).
agar plug diameter of 6 mm.
Figure 3Phylogenetic tree showing the relationship between an isolate Hypomontagnella monticulosa Zg15SU (Ο) and related Xylarian species bootstrap value (BV) ≥70%; the tree was inferred using neighbour-joining and Kimura 2-parameter method, modelled with a gamma distribution.
Antibacterial activity of EtOAc extracts from Zingiber griffithii rhizome and Hypomontagnella monticulosa Zg15SU mycelial extracts.
| No | Extract | Inhibition zone (mm) | |||
|---|---|---|---|---|---|
| MRSA | EPEC | ||||
| 1 | 10.25 ± 1.18 | 20.90 ± 0.93 | n.d | 12.75 ± 3.50 | |
| 2 | n.d | 10.35 ± 2.10 | n.d | n.d | |
| 3 | Chloramphenicol | 25.10 ± 2.56 | 40.90 ± 0.60 | n.d | 17.92 ± 1.52 |
n.d: no detectable inhibition zone.
mean diameter of inhibition zone ±S.D. (n = 3).
agar plug diameter of 6 mm.
Figure 4The GC-MS diagram of EtOAc extract from Zingiber griffthii rhizome and Hypomontagnella monticulosa Zg15SU mycelium.
The identified compounds and their relative peak area percentage of EtOAc extracts of Zingiber griffithii rhizome and Hypomontagnella monticulosa Zg15SU mycelial extracts.
| No. | Identified compounds | Peak area percentage (%) | |
|---|---|---|---|
| 1 | 1,2-Benzenedicarboxylic acid, ditridecyl ester | 8.81 | 2.23 |
| 2 | Cyclononasiloxane, octadecamethyl- | 2.32 | 30.44 |
| 3 | Diethyl Phthalate | 1.92 | 4.56 |
| 4 | Eicosanoic acid | 1.12 | 14.09 |
| 5 | Heptasiloxane, hexadecamethyl- | 21.18 | 1.20 |
| 6 | Isopropyl Palmitate | 0.17 | 0.08 |
| 7 | Nonanal | 0.08 | 0.14 |
| 8 | Octasiloxane | 1.09 | 0.02 |
| 9 | Oleic acid | 22.89 | 34.00 |
| 10 | Oleoyl chloride | 3.10 | 2.61 |
| 11 | Tridecanoic acid, methyl ester | 0.04 | 0.26 |
The NMR data of compound 1 at 1H (500 MHz) and 13C (125 MHz).
| No | 13C (CDCl3) | 1H (CDCl3) | Mult in | DEPT | HSQC | HMBC | COSY | |||
|---|---|---|---|---|---|---|---|---|---|---|
| CH3 | CH2 | CH | C | |||||||
| 1 | 39.7 | 1.56 | 2H, m | X | X | X | CH2 | 2 | ||
| 0.68 | ||||||||||
| 2 | 18.4 | 1.58 | 2H, m | X | X | X | CH2 | 1–3 | ||
| 1.35 | ||||||||||
| 3 | 41.9 | 1.33 | 2H, m | X | X | X | CH2 | 5 | 2 | |
| 1.14 | ||||||||||
| 4 | 33.28 | X | X | X | C | |||||
| 5 | 56.4 | 0.85 | 1H, m | X | X | X | CH | 6 | ||
| 6 | 17.9 | 1.39 | 2H, m | X | X | X | CH2 | 8–10 | 5–7 | |
| 1.58 | ||||||||||
| 7 | 41.4 | 1.70 | 2H, m | CH2 | 9 | 6 | ||||
| 1.12 | ||||||||||
| 8 | 36.8 | 1H, m | X | X | X | C | ||||
| 9 | 52.3 | 1.25 | 1H, m | X | X | X | CH | 11 | ||
| 10 | 37.7 | X | X | X | C | |||||
| 11 | 22.3 | 1.79 | 2H, m | X | X | X | CH2 | 9 | ||
| 1.66 | ||||||||||
| 12 | 74.4 | 4.87 | 1H, br t; 2.9 Hz | X | X | X | CH | 22 | 11 | |
| 13 | 37.6 | X | X | X | C | |||||
| 14 | 49.5 | 1.40 | 1H, m | X | X | X | CH | 15 | ||
| 15 | 24.0 | 2.36 | 2H, m | X | X | X | CH2 | 14 | ||
| 2.13 | ||||||||||
| 16 | 135.5 | 6.84 | 1H, d; 4.9; 3.5 Hz | X | X | X | CH | 17 | ||
| 17 | 51.0 | 3.14 | 1H, br q; 8.6, 4.8 Hz | X | X | X | CH | 16 | ||
| 18 | 21.33 | 0.80 | 3H, s | X | X | X | CH3 | 3-4-5-19 | ||
| 19 | 33.2 | 0.86 | 3H, s | X | X | X | CH3 | 3-4-5-18 | ||
| 20 | 16.2 | 0.82 | 3H, s | X | X | X | CH3 | 7-8-9 | ||
| 21 | 15.0 | 0.87 | 3H, s | X | X | X | CH3 | 12-13-14-17 | ||
| 22-OAc | 169.9 | |||||||||
| 23 | 21.39 | 1.96 | 3H, s | X | X | X | CH3 | 23 | ||
Figure 5The HMBC, 1H–1H COSY correlation and chemical structure of Compound (1) and (2).